Pharma

Translational medicine: Sanford-Burnham gets $100M donation

The research institute already has strong ties with the pharmaceutical industry. This donation is reflective of an overall increase in translational medicine - in these changing times, the biopharma industry has a growing reliance on academia

In a move that will amplify its already-strong ties with the pharmaceutical industry, Sanford-Burnham Medical Research Institute in San Diego just received a $100 million donation to hasten the academic development of new therapeutics.

This is reflective of an overall increase in translational medicine – in these changing times, the biopharma industry has a growing reliance on academia, a new Battelle report says.

The donation comes from philanthropist Conrad Prebys, a San Diego real estate tycoon.

“We should be doing all we can to shorten suffering and to extend people’s lives,” UT-San Diego reports. “Sanford-Burnham is the engine that is driving this ‘bench-to-bedside’ work. It’s going to pay dividends for a long, long time.”

This isn’t the first such gift to Sanford-Burnham: In January 2014, an anonymous donor gave the research institute an impressive $275 million for translational medicine.

Coupled with that announcement, Sanford-Burnham said it would up its partnerships with the pharmaceutical industry to move drug development forward. At the time, it hired away Perry Nisen, a senior VP at GlaxoSmithKline, to serve as Sanford-Burnham’s CEO.

Shares0
Shares0